Development of in vitro laboratory models of the tumor immune microenvironment to evaluate quality parameters and specific efficacy of the dendritic cell vaccine
Open Access
- 22 February 2023
- journal article
- research article
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 22 (1) , 82-94
Abstract
Purpose of the study:development ofin vitrolaboratory models to evaluate quality parameters and specific efficacy of dendritic cell vaccine (DCV).Material and Methods.Biological samples of malignant tumor patients treated with autologous dendritic cell vaccine (DC) were included into the study. Immature DCs (n=46) and mature DCs (n=56) were used to induce proliferation of antigen-specific T lymphocytes (n=227). Autologous tumor cells from skin melanoma (n=10) or sarcoma (n=8) patients in the xCELLigence® assay system were used to study thein vitroantitumor cytotoxic activity of generated CTLs (n=18). The secretion of cytokines and cytolytic proteins was studied by multiplex analysis. The subpopulation composition of effector T-lymphocytes was determined by flow cytometry.Results.We revealed that mature DCs (CD83+CD1a-) had a high expression of antigen presenting molecules (HLA-DR) and those providing migration of DCs into lymph nodes (CCR7) as well as costimulatory molecules CD80 and CD86 as compared to immature DCs (CD83-CD1a+). Induction of mature DCs was found to stimulate an increase in the relative content of proliferating T cells compared with stimulation of immature DCs (pin vitromodels using xCELLigence® analytical system and revealed 2 types of interaction: 1)in vitromodel № 1 – decrease in cell index (CI) of autologous tumor cell culture in the presence of activated effector T lymphocytes; 2)in vitromodel № 2 – no change in CI of autologous tumor cell culture when co-cultured with activated effector T cells compared to control (72 h observation). The results demonstrated cytotoxic activity of antigen-specific T lymphocytes due to high content of terminally differentiated cytotoxic T lymphocytes (TEMRA), GrB-producing CTLs, and cytokine secretion profile.Conclusion.Requirements for the quality of personalized autologous DCs, including control of immunophenotypic characteristics were developed, and functional activity of Tlymphocytes during induction of mature vaccine DCs was evaluated. A laboratory procedure was developed for quantitative assessment of cytotoxic activity of antigen-specific T-lymphocytes against autologous tumor using the xCELLigence® analytical system, thus allowing for personalized monitoring and predicting the effectiveness of DСV treatment.Keywords
This publication has 29 references indexed in Scilit:
- Comparison between xCELLigence biosensor technology and conventional cell culture system for real-time monitoring human tenocytes proliferation and drugs cytotoxicity screeningJournal of Orthopaedic Surgery and Research, 2017
- The immune contexture in cancer prognosis and treatmentNature Reviews Clinical Oncology, 2017
- Overview of Basic Immunology for Clinical Investigators2017
- Intratumoral oxygen gradients mediate sarcoma cell invasionProceedings of the National Academy of Sciences, 2016
- Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary resultsOncoTargets and Therapy, 2016
- Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisOncoImmunology, 2016
- Immunomonitoring in glioma immunotherapy: current status and future perspectivesJournal of Neuro-Oncology, 2015
- Perforin and granzymes: function, dysfunction and human pathologyNature Reviews Immunology, 2015
- In vitro generation of functional dendritic cells differentiated from CD34 negative cells isolated from human umbilical cord bloodCell Biology International, 2015
- Qualification of the COSTIM assay to determine potency and use in clinical trialsCytotherapy, 2013